BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Bordeaux Neurocampus - ECPv4.9.10//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:Bordeaux Neurocampus
X-ORIGINAL-URL:https://www.bordeaux-neurocampus.fr
X-WR-CALDESC:Évènements pour Bordeaux Neurocampus
BEGIN:VTIMEZONE
TZID:Europe/Paris
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20230326T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20231029T010000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;VALUE=DATE:20230320
DTEND;VALUE=DATE:20230408
DTSTAMP:20260606T163511
CREATED:20221118T145344Z
LAST-MODIFIED:20230315T102544Z
UID:152885-1679270400-1680911999@www.bordeaux-neurocampus.fr
SUMMARY:Cajal lectures: Neuro-vascular function in health and disease
DESCRIPTION:\nVenue: CGFB (except March 29th) \n\nMonday\, March 20th – 11:00am (Virtual talk)\nMalcolm MacLeod (University of Edinburgh\, UK)\nImproving preclinical stroke research. \nTuesday\, March 21st – 9:00am\nMartin Lauritzen (University of Copenhagen\, Denmark)\nHumoral Neurobiology: Brain blood vessels\, metabolism\, BBB and CSF dynamics. \nWednesday\, March 22nd – 9:00am\nDavid Attwell (University College London\, UK)\nRegulation of cerebral blood flow by capillary pericytes in stroke\, Alzheimer’s disease and Covid-19. \nWednesday\, March 22nd – 11:00am\nPierre Magistretti (EPFL\, Swiss)\nNeuron-Glia metabolic coupling mediated by lactate : role in neuroenergetics\, plasticity and pathologies. \nThursday\, March 23rd – 9:00am\nSerge Charpak (Vision Institute\, France)\nQuantification of neurovascular coupling and brain oxygenation dynamics. \nFriday\, March 24th – 9:00am\nAndy Shih (University of Washington\, USA)\nIn vivo optical dissection of brain capillary function. \nSaturday\, March 25th – 9:00am\nSusanne Van Veluw (Harvard Medical School\, USA)\nVasomotion-mediated perivascular clearance in cerebral amyloid angiopathy. \nWednesday\, March 29th – 9:00am\nFelipe Barros (Universidad San Sebastián\, Chile)\nVisualizing metabolic recruitment\, a partner for neurovascular coupling.\n⚠ This talk will take place at the Centre Broca \nThursday\, March 30th – 9:00am\nTurgay Dalkara (Hacettepe University Ankara\, Turkey)\nPost-ischemic CBF dysregulation in the brain and retina. \nFriday\, March 31st – 9:00am\nValentin Nagerl (University of Bordeaux\, France)\nShadow imaging of the micro-anatomy of living brain tissue. \nFriday\, March 31st – 11:00am\nPerimed : Presentation \nFriday\, March 31st – 11:45am\nBruker / Inscopix : Presentation \nMonday\, April 3rd – 9:00am\nRobert Thorne (University of Wisconsin-Madison\, USA)\nKey attributes of the CNS barriers and brain microenvironment: relevance for physiology and drug delivery \nMonday\, April 3rd – 11:00am\nJean-François Ghersi-Egea (CRNL\, France)\nThe choroid plexus-cerebrospinal fluid system in brain physiology\, pathology\,and pharmaco-toxicology. \nWednesday\, April 5th – 9:00am\nAndy Obenhaus (University of California Irvine\, USA)\nModification of the cerebrovasculature in neurodegenerative disease. \nThursday\, April 6th – 9:00am\nAnne Joutel (Institute of Psychiatry and Neurosciences of Paris\, France)\nDeciphering mechanisms of small vessel diseases of the brain. \n\n\n\n\n\n\n\n\n\n\n\nAbout the Cajal lectures\nThe Cajal lectures are organized in the frame of the Cajal courses\, located in the Bordeaux school of Neuroscience. They are open to everyone. \nMore details about this course:\nhttps://cajal-training.org/on-site/neuro-vascular/\n \n\n\nCourse directors\n\n\n\n\n\n\n\n\n\n\n\n\nNikolaus Plesnila\, Ludwig Maximilian University\, Germany \n\n\n\n\n\n\n\n\n\n\n\n\n\n\nJérôme Badaut\, Bordeaux University\, France \n\n\n\n\n\n\n\n\n\n\n\n\n\n\nCatherine Hall\,Sussex University\, UK \n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n
URL:https://www.bordeaux-neurocampus.fr/event/cajal-lectures-neuro-vascular-function-in-health-and-disease/
CATEGORIES:A la une,Cajal Lectures,Pour les scientifiques
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/Paris:20230330T100000
DTEND;TZID=Europe/Paris:20230330T140000
DTSTAMP:20260606T163511
CREATED:20230322T152304Z
LAST-MODIFIED:20230322T153026Z
UID:157574-1680170400-1680184800@www.bordeaux-neurocampus.fr
SUMMARY:Stand commercial - PROTEIGENE
DESCRIPTION:Lieu : Hall de l’institut François Magendie \n\nSite web : https://proteigene.com/ \n
URL:https://www.bordeaux-neurocampus.fr/event/stand-commercial-proteigene/
CATEGORIES:A la une,Stand ou séminaire commercial
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/Paris:20230330T103000
DTEND;TZID=Europe/Paris:20230330T103000
DTSTAMP:20260606T163511
CREATED:20230227T132303Z
LAST-MODIFIED:20230711T130525Z
UID:156235-1680172200-1680172200@www.bordeaux-neurocampus.fr
SUMMARY:MRGM Seminar - Thomas Langer
DESCRIPTION:Venue: Centre Broca Nouvelle-Aquitaine \n\nThomas Langer\nMax Planck Institute for Biology of Ageing\nKöln\, Germany \nInvited by Giovanni Bénard\, Laboratoire Maladies Rares\, Génétique et Métabolisme (MRGM) \nTitle\nProgramming of mitochondria by proteolysis \nAbstract\nMitochondria are essential metabolic organelles and integral part of numerous cellular signaling pathways. Cellular signals determine the composition of the mitochondrial proteome and the metabolic output of mitochondria\, which influence cell fate during development\, cell differentiation\, in ageing and disease. Mitochondrial proteases are emerging as central regulators of these adaptive responses. The i-AAA protease YME1L regulates in concert with the stress-activated peptidase OMA1 mitochondrial fusion via OPA1 and couples mitochondrial shape and metabolic function. YME1L activation promotes growth of pancreatic ductal adenocarcinoma cells and preserves the self-renewal capacity of adult neural stem cells. OMA1 also promotes the integrated stress response by DELE1 cleavage and protects against cardiomyopathy induced by OXPHOS dysfunction. The mitochondrial rhomboid protease PARL\, an intramembrane cleaving serine peptidase\, has been linked to the assembly of respiratory complex III\, coenzyme Q synthesis\, PINK1-Parkin dependent mitophagy and the resistance against apoptosis and ferroptosis. Recent findings on novel roles of these proteases for the functional plasticity of mitochondria will be discussed. \nCurriculum Vitae\nThomas Langer\, born in 1964 in Straubing Germany\, studied Biological Science at the University of Regensburg and graduated in the same subject at the Ludwigs-Maximilians-Unviersität of Munich. During his PhD he had the possibility to be a visiting scientist at the Memorial Sloan-Kettering Cancer Institute in New York\, USA.  In 1996 he finally became a group leader at the Collaborative Research Centre 194 of the German Research Council in Munich. In the meantime\, he passed the habilitation and consequently became a Professor of biochemistry at the Institute of Genetics of the University of Cologne in 2001. Since 2018 he leads his own department “mitochondrial proteostasis” as a Director at the Max Planck Institute for Biology of Ageing in Cologne\, where after only one year he was appointed as the Managing Director.\nResearch Interests\nThomas Langer’s research investigates the role of mitochondrial proteases for the maintenance of mitochondrial function during aging and age-related diseases. The aim is to understand the molecular mechanisms that contribute to the preservation of mitochondrial function during ageing and enable a dynamic adaptation of the cell- and tissue-specific mitochondrial proteome. He already received numerous awards for his research in the field of mitochondrial proteostasis. In 2017 he was awarded the Max Delbrück Prize from the University of Cologne. In 2016 he received the Wilhelm Feldberg Prize preceded by the Reinhart Koselleck Grant of the German Research Council.\n
URL:https://www.bordeaux-neurocampus.fr/event/seminar-thomas-langer/
CATEGORIES:A la une,Hors Bordeaux Neurocampus
END:VEVENT
END:VCALENDAR